Literature DB >> 22109909

Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making.

Alison D Archibald1, Belinda J McClaren.   

Abstract

Year:  2011        PMID： 22109909      PMCID： PMC3266967          DOI： 10.1007/s12687-011-0067-8

Source DB:  PubMed          Journal:  J Community Genet        ISSN： 1868-310X


× No keyword cloud information.
  38 in total

Review 1.  Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review.

Authors:  Lei-Shih Chen; Patricia Goodson
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

2.  The influence of experiential knowledge on prenatal screening and testing decisions.

Authors:  Holly Etchegary; Beth Potter; Heather Howley; Mario Cappelli; Doug Coyle; Ian Graham; Mark Walker; Brenda Wilson
Journal:  Genet Test       Date:  2008-03

3.  "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Authors:  Alison D Archibald; Alice M Jaques; Samantha Wake; Veronica R Collins; Jonathan Cohen; Sylvia A Metcalfe
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

4.  A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study.

Authors:  Sylvia Metcalfe; Alice Jacques; Alison Archibald; Trent Burgess; Veronica Collins; Anna Henry; Kathleen McNamee; Leslie Sheffield; Howard Slater; Samantha Wake; Jonathan Cohen
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822

5.  Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.

Authors:  John Massie; Vicki Petrou; Robyn Forbes; Lisette Curnow; Liane Ioannou; Desiree Dusart; Agnes Bankier; Martin Delatycki
Journal:  Aust N Z J Obstet Gynaecol       Date:  2009-10       Impact factor: 2.100

Review 6.  Population genetic screening programmes: principles, techniques, practices, and policies.

Authors:  Béatrice Godard; Leo ten Kate; Gerry Evers-Kiebooms; Ségolène Aymé
Journal:  Eur J Hum Genet       Date:  2003-12       Impact factor: 4.246

7.  'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening.

Authors:  Belinda J McClaren; Martin B Delatycki; Veronica Collins; Sylvia A Metcalfe; MaryAnne Aitken
Journal:  Eur J Hum Genet       Date:  2007-12-05       Impact factor: 4.246

Review 8.  A systematic review of population screening for fragile X syndrome.

Authors:  Melissa K Hill; Alison D Archibald; Jonathan Cohen; Sylvia A Metcalfe
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

9.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

10.  Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling.

Authors:  Alexandra A Gason; Sylvia A Metcalfe; Martin B Delatycki; Vicki Petrou; Edith Sheffield; Agnes Bankier; Maryanne Aitken
Journal:  Genet Med       Date:  2005 Nov-Dec       Impact factor: 8.822
View more
  6 in total

1.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

2.  Evaluation of two-year Jewish genetic disease screening program in Atlanta: insight into community genetic screening approaches.

Authors:  Yunru Shao; Shuling Liu; Karen Grinzaid
Journal:  J Community Genet       Date:  2015-01-07

3.  Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.

Authors:  Alice G Ames; Alice Jaques; Obioha C Ukoumunne; Alison D Archibald; Rony E Duncan; Jon Emery; Sylvia A Metcalfe
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

4.  Exploring approaches to facilitate family communication of genetic risk information after cystic fibrosis population carrier screening.

Authors:  Anita Gorrie; Alison D Archibald; Liane Ioannou; Lisette Curnow; Belinda McClaren
Journal:  J Community Genet       Date:  2017-10-02

5.  A qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy.

Authors:  Celine Lewis; Melissa Hill; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2016-08-23       Impact factor: 3.050

6.  Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.

Authors:  Kim C A Holtkamp; Inge B Mathijssen; Phillis Lakeman; Merel C van Maarle; Wybo J Dondorp; Lidewij Henneman; Martina C Cornel
Journal:  Eur J Public Health       Date:  2017-04-01       Impact factor: 3.367
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.